Agios Pharmaceuticals Inc (AGIO)
58.61
-0.41
(-0.69%)
USD |
NASDAQ |
Nov 13, 16:00
58.61
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Revenue (Annual): 26.82M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.82M |
| December 31, 2022 | 14.24M |
| December 31, 2021 | |
| December 31, 2020 | |
| December 31, 2019 | |
| December 31, 2018 | 94.39M |
| December 31, 2017 | 43.01M |
| Date | Value |
|---|---|
| December 31, 2016 | 69.89M |
| December 31, 2015 | 59.12M |
| December 31, 2014 | 65.36M |
| December 31, 2013 | 25.55M |
| December 31, 2012 | 25.11M |
| December 31, 2011 | 21.84M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
14.24M
Minimum
2022
26.82M
Maximum
2023
20.53M
Average
20.53M
Median
Revenue (Annual) Benchmarks
| Pfizer Inc | 58.50B |
| Regeneron Pharmaceuticals Inc | 13.12B |
| Ligand Pharmaceuticals Inc | 131.31M |
| ADMA Biologics Inc | 258.22M |
| AnaptysBio Inc | 17.16M |